Postgrad LIVE! Study Fairs

Birmingham | Edinburgh | Liverpool | Sheffield | Southampton | Bristol

University of Bristol Featured PhD Programmes
Birkbeck, University of London Featured PhD Programmes
Imperial College London Featured PhD Programmes
University of Oxford Featured PhD Programmes
Max Planck Society Featured PhD Programmes
10 miles

University of Oxford Cancer / Oncology PhD Projects, Programs & Scholarships

We have 54 University of Oxford Cancer / Oncology PhD Projects, Programs & Scholarships

  • Cancer / Oncology×
  • University of Oxford×
  • clear all
Order by 
Showing 1 to 10 of 54
  DPhil CASE studentship in Inorganic/Physical Chemistry: Developing an On-Chip Reagentless Cancer screen
  Prof J Davis
Application Deadline: 25 January 2019
Start Date. as soon as possible, or October 2019 at the latest. Supervisor. Professor Jason Davis (research webpage. https://www.jjdgroup.co.uk ).
  A Gastrointestinal Epithelial Organoid Assay to Identify Non-Toxic Chemoradiation Combinations for Cancer Treatment
  Prof A Kiltie, Prof A Ryan
Application Deadline: 11 January 2019
Every year worldwide half a million patients receive radiotherapy to their abdomen and/or pelvis for tumours including rectal, oesophageal, bladder, prostate or cervix cancer.
  A STING in the Tail for Cancer
  Prof P McHugh, Prof A Harris
Application Deadline: 11 January 2019
Recently, we described the accumulation of small cytoplasmic DNA fragments after therapeutic DNA damage, including radiotherapy and chemotherapy (Erdal et al, Genes & Dev.
  Characterisation of DNA-protein crosslink proteolysis repair
  Prof K Ramadan, Prof B Kessler
Application Deadline: 11 January 2019
DNA-protein crosslinks (DPCs) are under-investigated DNA lesions caused by the covalent attachment of proteins to DNA. DPCs are induced by endogenous aldehydes or chemotherapeutic drugs.
  Cross-presentation of exogenous ROP proteins by antigen presenting cells to MHC class I and class II pathways
  Dr S Jiang, Dr N Burgess-Brown
Application Deadline: 11 January 2019
Immunotherapy including therapeutic vaccines provides great hope for cancer treatment. Understanding the mechanisms of antigen presentation is helpful for optimal design of an immunotherapy.
  Deciphering the regulation of non-coding RNAs in a hypoxic tumour microenvironment
  Prof F Buffa, Prof A Harris
Application Deadline: 11 January 2019
The role of the microenvironment in driving tumour progression is increasingly recognized. Hypoxia is one of the key microenvironmental changes between tumour and normal tissue, and adaptation of cancer cells to this hostile environment contributes to their malignancy and aggressive phenotype (1).
  Determinants of Sensitivity to G-Quadruplex-Binding Compounds
  Prof M Tarsounas, Prof A Ryan
Application Deadline: 11 January 2019
The observation that BRCA1 and BRCA2 deficient cells and tumours are sensitive to G-quadruplex (G4) ligands has spurred development of cancer therapies using these molecules to target homologous recombination deficiencies.
  Development of Tracers for Real-Time Endoscopic Optical Imaging for Early Detection of Oesophageal Cancer
  Prof K Vallis, Prof B Vojnovic
Application Deadline: 11 January 2019
The incidence of oesophageal cancer is rising worldwide and it is recognised as a cancer of unmet need since overall survival remains persistently low.
  Dissecting the Determinants of Response to Checkpoint Inhibitors
  Dr B Fairfax, Prof M Middleton
Application Deadline: 11 January 2019
Cancer treatment is being revolutionised by checkpoint inhibitor immunotherapy (CKI). In melanoma, where there is limited role for radiotherapy or chemotherapy, CKI forms the frontline treatment.
  Efficient homing of natural killer
  Prof N Sibson, Prof A Giaccia
Application Deadline: 11 January 2019
Efficient homing of natural killer (NK) cells in the tumor microenvironment (TME) is essential for NK mediated anti-tumor effector function.
Show 10 15 30 per page


FindAPhD. Copyright 2005-2018
All rights reserved.